Literature DB >> 24745161

[Diagnosing polycystic ovary syndrome in adolescent girls].

Agnieszka Drosdzol-Cop, Agata Sidło-Stawowy, Dominika Sajdak, Violetta Skrzypulec-Plinta.   

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies and it manifests itself in about 4-12% women of reproductive age. The Rotterdam, AES and NIH criteria can be used to diagnose PCOS in adults but there are no specific criteria to diagnose PCOS in adolescent girls. Most authors agree that applying criteria for adult to teenagers leads to overdiagnosis because of similarity in physiological changes during puberty and common PCOS symptoms. Tightening of the current criteria and including new, not widely accepted yet, was proposed. Currently it seems justifiable to diagnose PCOS in adolescent girls using the Rotterdam criteria, on condition that all three symptoms are present, hyperandrogenism is established in laboratory tests and pelvic ultrasound reveals an increased ovarian volume (> 10 ml). Nevertheless, the necessity of more research and establishing specific criteria for adolescent girls is emphasized.

Entities:  

Mesh:

Year:  2014        PMID: 24745161     DOI: 10.17772/gp/1705

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  2 in total

1.  The relationship between the level of vitamin D, leptin and FGF23 in girls and young women with polycystic ovary syndrome.

Authors:  Agnieszka Białka-Kosiec; Dominika Orszulak; Aneta Gawlik; Agnieszka Drosdzol-Cop
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

2.  Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome.

Authors:  Małgorzata Mizgier; Grażyna Jarząbek-Bielecka; Natalia Wendland; Elżbieta Jodłowska-Siewert; Marcin Nowicki; Alicja Brożek; Witold Kędzia; Dorota Formanowicz; Justyna Opydo-Szymaczek
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.